Because decreased QOL in CRC is considered to be associated with immune system alterations and chronic systemic inflammation, it is possible that the pro-inflammatory adipokine chemerin may be associated with QOL in CRC survivors. This evidence concerns the gene RARRES2 and colorectal carcinoma.